News

According to the company, the MGuard stent system presents a novel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by

Wyeth is seeking an indication for the prevention of pneumococcal disease caused by the 13 serotypes included in the investigational vaccine in infants and children from two months

Through the special protocol assessment (SPA), the FDA has agreed that if the 131I-TM601 Phase III study successfully meets its stated endpoints, the design and planned analysis of

According to the company, both the PN 400-301/302 studies achieved the primary endpoints. Subjects taking PN 400 experienced statistically significantly fewer endoscopically confirmed gastric ulcers on PN 400

The current 10.6 month median overall survival advantage observed in the OGX-011 arm represents an increase over the median survival observed in the control arm. Docetaxel was approved

The US Patent and Trademark office has issued a patent for the exclusive use of a vaccine comprised of the two most prevalent surface antigens in Staphylococcus aureus

The Medtronic Sprint Quattro Secure S lead is designed with an 8.6 French diameter lead body. A thin wire inserted into the chambers of the heart through blood

As part of this filing, the company is seeking court approval of a sales procedures motion that will allow Introgen to market its therapeutic portfolio and other assets

The issued claims not only focus on siRNA but also include specific claims directed to micro RNA (miRNA), pre-miRNA, and short hairpin RNA (shRNA). This patent issues from